R. Lenzi Et Al. , "Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy," CANCER INVESTIGATION , vol.20, no.4, pp.464-472, 2002
Lenzi, R. Et Al. 2002. Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. CANCER INVESTIGATION , vol.20, no.4 , 464-472.
Lenzi, R., Yalcin, S., Evans, D., & Abbruzzese, J., (2002). Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. CANCER INVESTIGATION , vol.20, no.4, 464-472.
Lenzi, R Et Al. "Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy," CANCER INVESTIGATION , vol.20, no.4, 464-472, 2002
Lenzi, R Et Al. "Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy." CANCER INVESTIGATION , vol.20, no.4, pp.464-472, 2002
Lenzi, R. Et Al. (2002) . "Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy." CANCER INVESTIGATION , vol.20, no.4, pp.464-472.
@article{article, author={R Lenzi Et Al. }, title={Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy}, journal={CANCER INVESTIGATION}, year=2002, pages={464-472} }